Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Sample Size Calculation01:19

Sample Size Calculation

Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
Bonferroni Test01:10

Bonferroni Test

The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
Binomial Probability Distribution01:15

Binomial Probability Distribution

A binomial distribution is a probability distribution for a procedure with a fixed number of trials, where each trial can have only two outcomes.
The outcomes of a binomial experiment fit a binomial probability distribution. A statistical experiment can be classified as a binomial experiment if the following conditions are met:
There are a fixed number of trials. Think of trials as repetitions of an experiment. The letter n denotes the number of trials.
There are only two possible outcomes,...
Wilcoxon Signed-Ranks Test for Matched Pairs01:09

Wilcoxon Signed-Ranks Test for Matched Pairs

The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive value of miR-151a-3p for the onset of sepsis-induced acute kidney injury and its functional role during disease development.

BMC immunology·2026
Same author

Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial.

Neuropsychiatric disease and treatment·2026
Same author

Serum LINC01127 serves as a diagnostic biomarker for sepsis and its predictive value for clinical outcomes.

Hereditas·2026
Same author

Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial.

The American journal of psychiatry·2026
Same author

Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.

The American journal of psychiatry·2025
Same journal

Checking Genetic Homogeneity Between Two Samples Using Summary Statistics With Application to Mendelian Randomization.

Statistics in medicine·2026
Same journal

A Bayesian Learning Model for Joint Risk Prediction of Alcohol and Cannabis Use Disorders.

Statistics in medicine·2026
Same journal

Reluctant Transfer Learning in Penalized Regressions for Individualized Treatment Rules Under Effect Heterogeneity.

Statistics in medicine·2026
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Sample size calculation for comparing two negative binomial rates.

Haiyuan Zhu1, Hassan Lakkis

  • 1Forest Research Institute, Harborside Financial Center, Jersey City, NJ 07311, U.S.A.

Statistics in Medicine
|September 17, 2013
PubMed
Summary
This summary is machine-generated.

A new formula simplifies sample size estimation for clinical trials using the negative binomial model, addressing overdispersed count data common in research.

Keywords:
count datanegative binomial modelpower analysissample size calculation

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: May 7, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Modeling

Background:

  • The negative binomial model is increasingly preferred over the Poisson model for analyzing overdispersed count data in clinical trials.
  • Accurate sample size estimation is a critical challenge when applying the negative binomial model in clinical trial design.
  • Current methods often rely on computationally intensive simulation approaches for sample size determination.

Purpose of the Study:

  • To develop an explicit, accurate formula for sample size calculation based on the negative binomial model.
  • To provide practical tools for researchers designing clinical trials with count data.
  • To assess the performance of the proposed formula variations.

Main Methods:

  • Derivation of an explicit sample size formula tailored for the negative binomial distribution.
  • Development of three formula variations based on different approaches for estimating variance under the null hypothesis.
  • Assessment of formula performance and accuracy through simulation studies.

Main Results:

  • An accurate, explicit formula for sample size calculation using the negative binomial model has been successfully developed.
  • The proposed formula explicitly incorporates key parameters such as dispersion and exposure time.
  • Simulations demonstrate the reliable performance of the formula and its variations.

Conclusions:

  • The developed explicit formula offers a more direct and efficient method for sample size estimation in negative binomial regression for clinical trials.
  • This provides a valuable alternative to simulation-based methods, enhancing the practicality of trial design.
  • The formula's ability to incorporate dispersion and exposure time improves the precision of sample size calculations.